| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Race Oncology Limited (AU: RAC)
RAC Technical Analysis
5
| As on 11th Jul 2023 RAC STOCK Price closed @ 1.51 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.26 & Strong Sell for SHORT-TERM with Stoploss of 2.82 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RACSTOCK Price
| Open | 1.31 | Change | Price | % |
| High | 1.51 | 1 Day | 0.21 | 16.15 |
| Low | 1.31 | 1 Week | 0.28 | 22.76 |
| Close | 1.51 | 1 Month | 0.00 | 0.00 |
| Volume | 265614 | 1 Year | -1.49 | -49.67 |
| 52 Week High 3.10 | 52 Week Low 1.16 | ||||
AU Australia Most Active Stocks
| MOB | 0.02 | 100.00% |
| SI6 | 0.01 | % |
| GMN | 0.01 | 0.00% |
| LPD | 0.01 | 0.00% |
| LDX | 0.06 | -14.29% |
| S32 | 3.69 | 3.65% |
| WWI | 0.02 | 100.00% |
| HWK | 0.09 | % |
| SYA | 0.19 | 5.56% |
| G88 | 0.05 | -16.67% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| RAC Daily Charts |
RAC Intraday Charts |
Whats New @ Bazaartrend |
RAC Free Analysis |
|
|
RAC Important Levels Intraday
| RESISTANCE | 1.90 |
| RESISTANCE | 1.77 |
| RESISTANCE | 1.70 |
| RESISTANCE | 1.62 |
| SUPPORT | 1.40 |
| SUPPORT | 1.32 |
| SUPPORT | 1.25 |
| SUPPORT | 1.12 |
RAC Forecast May 2024
| 4th UP Forecast | 3.32 |
| 3rd UP Forecast | 2.74 |
| 2nd UP Forecast | 2.38 |
| 1st UP Forecast | 2.02 |
| 1st DOWN Forecast | 1 |
| 2nd DOWN Forecast | 0.64 |
| 3rd DOWN Forecast | 0.28 |
| 4th DOWN Forecast | -0.3 |
RAC Weekly Forecast
| 4th UP Forecast | 2.09 |
| 3rd UP Forecast | 1.90 |
| 2nd UP Forecast | 1.79 |
| 1st UP Forecast | 1.67 |
| 1st DOWN Forecast | 1.35 |
| 2nd DOWN Forecast | 1.23 |
| 3rd DOWN Forecast | 1.12 |
| 4th DOWN Forecast | 0.93 |
RAC Forecast2024
| 4th UP Forecast | 5.38 |
| 3rd UP Forecast | 4.14 |
| 2nd UP Forecast | 3.37 |
| 1st UP Forecast | 2.61 |
| 1st DOWN Forecast | 0.41 |
| 2nd DOWN Forecast | -0.35 |
| 3rd DOWN Forecast | -1.12 |
| 4th DOWN Forecast | -2.36 |
Race Oncology Limited ( AU Australia Symbol : RAC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RAC Business Profile
Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein for treating for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia. Address: Gateway, 1 Macquarie Place, Sydney, NSW, Australia, 2000
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service